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Abstract
Bovine mastitis is an important commercial 
and sanitary cost in milk production. The 
prevention and treatment of this disease is 
essentially based on the use of antibiotics that 
have limited effectiveness and can negatively 
affect milk quality. The aim of this study was 
to evaluate the effectiveness of an alternative 
treatment based on a symbiotic in the control 
and prevention of subclinical mastitis (SCM), 
and in the improvement of the quality of milk 
produced on a dairy farm in north-central 
Algeria. The milk of 68 cows was collected 
and analysed by somatic cell count and 
bacteriological analysis. Three samples were 
taken at one-month intervals. The first sample 
was taken before the administration of a feed 
additive (SYMBIOVEBA®) to lactating dairy 
cows. Animals were divided into two groups 
to study the effects (curative and preventive) of 
the symbiotic. Each group was further divided 
into two subgroups, where one received 
the symbiotic and the other was the control. 
The prevalence of subclinical mastitis at this 
farm was 33.82%. Bacterial identification was 
performed using classical methods only on 
the group of cows with mastitis; a total of 
13 bacterial species were isolated from the 
three samples. Staphylococci were dominant, 
with a frequency of 45%, followed by 
Enterobacteriaceae (40%). These rates were 
considerably lower in both subgroups, 
though treated cows showed 100% cure rate 
for both Staphylococci and Enterobacteriaceae. 
Individual somatic cell count (ISCC) was 
performed on all three samples and in both 
groups, and revealed a cure threshold (S) of 
200,000 cells/mL, and a 100% cure rate for 
the SYMBIOVEBA®-treated cow subgroup 
compared to 62.5% for the control subgroup 
(P<0.05). 
Key words: dairy cow; subclinical mastitis; 
bacteriology; ISCC; symbiotic
Introduction
Mastitis is the primary cause of 
economic losses for dairy ruminant 
farms, incurring costs of several million 
euros per year (Gračner et al., 2006; 
Maćešić et al., 2012; Saidi et al., 2013; 
Kovačić et al., 2019; Nedić et al., 2019; 
Cvetnić et al., 2016a, b; Đuričić et al., 
2017). Costs are due to a drop in milk 
production, issues of raw material 
processability, premature culling of 
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animals with clinical or chronic mastitis, 
treatment costs (veterinary products and 
fees), and financial penalties on milk 
quality based on somatic cell count (SCC) 
(Benić et al., 2018; Burović, 2020). Many 
health problems can also result from the 
lower quality of the raw material. Indeed, 
the presence of bacteria in milk following 
the milking of infected animals can lead 
to contamination throughout the dairy 
chain, causing food poisoning (Cvetnić et 
al., 2016b; Saidi et al., 2021a).
Clinical mastitis is a serious problem 
on dairy farms and can be visually 
detected, whereas detection of SCM 
requires monitoring of milk cell counts by 
indirect and/or direct methods (M’sadak 
et al., 2014; Maćešić et al., 2016; Đuričić et 
al., 2017; Turk et al., 2017).
Meanwhile, consumer expectations 
of food are changing, with increasing 
questioning of the quality of what is 
being offered by current agriculture, 
including animal production. There is 
also a limited fear among the population 
of the risk of antibiotic residues in food 
resulting from the systematic use of 
these molecules in animal husbandry 
(Cvetnić et al., 2016c; Saidi et al., 2021b). 
In order to keep up with consumer 
expectations, it seems necessary to 
reduce the number of treatments per 
cow, which of course means better 
reasoning for the treatments, above all to 
reduce the prevalence of new infections. 
However, mastitis is a multifactorial 
problem that can only be resolved by 
addressing some of the risk factors 
present in animal husbandry (Turk et al., 
2012; Kleczkowski et al., 2017). This is 
why, apart from the identification of the 
mechanisms of infection propagation, it 
becomes necessary to set up prevention 
measures, such as feed additives, that 
improve the zootechnical performance of 
cow and improve individual resistance 
to pathogens (Đuričić et al., 2017).
The objectives of this study were to 
evaluate the prevalence of SCM through 
the measurement of individual somatic 
cell count (ISCC), to identify the bacteria 
involved, and to study the evolution 
of bacteriology after administration 
of a symbiotic aimed at improving 
the zootechnical performances of the 




This study began in February 2017 
and was completed in May 2017 on a 
farm located in the Tipaza region (north-
central Algeria). The cows on the farm 
are of the Fleckvieh breed imported from 
Austria. They live in a free stall building 
with natural ventilation, the floor is 
equipped with a sleeping mat, and 
cleaning is performed by an automatic 
scraper 3 times per day.
Milking is done twice a day by a 2 x 
5 automatic milking machine. Mastitis 
cows are treated in the pot with two 
extra claws. All milking operations are 
performed by the farm technician.
Animals included in the study
Pre-selection was conducted for all 
cows in the herd in the lactation phase. 
The exclusion criteria were: local or 
general antibiotic treatment, cows with 
inter-current disease and cows during 
dry-off. Finally, 68 lactating cows were 
included in the study, where 45 received 
the symbiotic once a month after the 
first milk sampling; This represented 
a sampling rate of about 87% for the 
lactating cows (78 cows), and about 45% 
for all the cows of this farm with a total 
of 150 cows.
Methods
Mastitis case definition and cure 
evaluation criteria
In this experimental plan, mastitis 
was defined as an udder with a cell count 
greater than or equal to the threshold 
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(S) for cure or non-infection, i.e., 200,000 
cells/mL of milk (Boutet et al., 2006).
Each case of SCM was then defined 
as the starting point for the routing of 
samples for bacteriology. Cow recovery 
was assessed using CCSI in relation to 
the threshold (S) as detailed in the table 
below.





≥ S ≥ S Not recovered
≥ S < S Apparent recovery
< S < S Clean
< S ≥ S Infection
The bacteriological recovery of the 
udders, on the other hand, implies the 
absence of bacteria in the milk sample 




The evolution of SCM was monitored 
at the microbiological and cellular level 
by taking three milk samples at intervals 
of approximately 1 month between 
samples; i.e., on day 0 (D0; where the 
cell count allowed for definition of cow 
subgroups), then on day 31 (D31), and 
finally on day 64 (D64).
Milk samples were taken from the 68 
cows selected for this study, in order to 
first perform the somatic cell count and 
thus determine the infected udders. This 
first sample was the starting point of the 
udder infection evaluation. Samples with 
a cell count of or exceeding 200.000 cells/
mL were sent to the laboratory and sub-
jected to bacteriological examination. The 
sample volume was approximately 20 
millilitres. Each udder was then resam-
pled approximately one month after the 
first sample was taken to perform the cell 
count and bacteriological analysis.
The final sample was taken 1 month 
after the second sample to perform 
the final cell count and bacteriological 
examination in order to estimate the 
effect of the symbiotic additive on the 
performance of dairy cows and their 
subsequent resistance to pathogens.
All samples were kept at a temperature 




The additive used in this study 
was SYMBIOVEBA® (MARCOPOLO 
Environmental Group), a purely 
biological feed additive for veterinary 
use. After oral administration, this 
additive rebalances rumen PH, improves 
zootechnical performance, prevents 
digestive disorders, strengthens the 
immune system, and maintains the good 
general condition of the animal.
The composition of this product is 
as follows: medicinal plants (Taraxacum 
officinalis, Zingiber officinalis), probiotics 
(Lactobacillus & Saccharomycess cervicia), 
enzymes, plant extracts and water, 
obtained with an exclusive MESEN 
patented process.
Additive administration
The addition of the symbiotic to the 
cows’ diet was for 2/3 of cows with a 
cell count was greater than 200.000 cells/
mL, and 2/3 of the cows with a cell count 
of less than 200.000 cells/ml. This was 
done once a month, in accordance with 
the described dosage of this symbiotic, 
after the first two samples: D0 just after 
the first milk sampling and the first cell 
count, and D31 after the second sampling
Therefore, the test population was 
divided into four subgroups based on 
cell count in order to clearly demonstrate 
the effect of the symbiotic on resistance 
to udder infections in different situations.
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Following this distribution, two 
groups were formed:
1. Study of the curative effect of the 
symbiotic within Group 1 initially 
affected by mastitis and divided 
into the test (A) and control (B) 
subgroups, and 
2. Study of the preventive effect 
of the symbiotic within Group 
2 initially free of mastitis and 
divided into the test (C) and 
control (D) subgroups.
Cell count 
The somatic cell count was performed 
on site at the farm, using a DeLaval 
Cell Counter® device. Cell counts were 
performed on all three monthly samples 
in both groups.
Bacteriological examination
Bacteriological examination was 
carried out at the microbiology laboratory 
of the Salim Zemirli Hospital (Algiers, 
Algeria) on all the monthly samples of 
Group 1.
During the first reading at 24 hours, 
all types of isolated colonies were 
transplanted onto Columbia agar to 
obtain a pure culture. In the absence of 
visible bacterial growth, the enrichment 
broth was transferred to 5% sheep blood 
Columbia agar.
On the second reading at 48 hours, 
direct isolation and post-enrichment 
culture was observed. If new colony 
types were observed, they were isolated 
as before. At this stage, the reading of 
the direct isolation was complete and 
sample quality could be determined. Any 
isolation of more than two colony types 
should be considered contaminated. In 
this study, we consider that samples 
with two colony types were bi-microbial 
infections.
Table 3. Evaluation of sample quality (according 
to COFRAC/CNEVA*)
Number 






2 Bi-microbial contamination or infection
>2 Contamination of the sample
* COFRAC/CNEVA 1996: Pr 116/00BA 140/00, Isolation 
and identification of the main mastitis germs in 
ruminants.
When direct isolation revealed 
bacteria, enrichment was not taken into 
account. In the same way, any result 
where no culture was obtained directly 
and where the bacteria isolated after 
enrichment was not an Enterobacterium 
could be considered questionable. 
When no culture was obtained directly 
and an Enterobacterium was isolated 
after enrichment, this bacterium was 
considered responsible for the mastitis. 
This precision is necessary because 
Seynod’s LIDAL always provides 
coupled results of direct isolation and 
Table 2. Distribution of the symbiotic (SYMBIOVEBA®) on the four subgroups of lactating cows
Group SCC Subgroup Treatment Number of cows
1 ≥ 200.000 cells/mL
A (Test) Symbiotic 15
B (Control) None 8
2 < 200.000 cells/mL
 C (Test) Symbiotic 30
 D (Control) None 15
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enrichment (Noireterre, 2006). These 
results require interpretation.
Identification
Identification to the genus level was 
carried out by the appearance of colonies 
on agar and by Gram staining, as well as 
the search for catalase for Gram + bacteria 
and oxidase for Gram - bacteria.
Staphylococci thus appear as spheres, 
at Gram + and catalase +. The affinity 
factor for fibrinogen or the “clumping 
factor” or bound coagulase was tested for 
with the rapid slide test. Free coagulase 
was not detected by this test. All bacteria 
producing bound coagulase were 
identified as S. aureus. If the germ was 
β-haemolytic and the bound coagulase 
was negative, free coagulase was tested 
for with the tube test. Following this 
second test, all positive colonies were 
definitively identified as S. aureus.
All other bacteria were classified as 
CNS (coagulase-negative Staphylococci). 
The CNS were then identified with the 
study of 20 metabolic, fermentative, 
ADH characteristics on Api Staph® 
galleries from BIOMERIEUX. It is 
certain that this determination pattern 
qualifies as S. aureus coagulase-positive 
staphylococci non-aureus (S. intermedius, 
certain strains of S. hyicus). In addition, 
some coagulase-positive staphylococci 
(CPS) were not detected. Thus, all CPS 
were identified as S. aureus in the rest of 
the study. The identification of CNS at 
the species level using the Api Staph® 
galleries was unreliable because of the 
very limited number of tests used (Bes 
et al., 1999).
The genera Streptococcus and 
Enterococcus were identified as Gram 
+, catalase - and oxidase - cocci. The 
colonies were then transferred to agar 
by flooding. Then, the bacterial species 
were determined by the Api20 Strep® 
gallery, which explores 20 enzymatic and 
fermentation properties of the germs. 
Enterobacteriaceae were identified as 
Gram-, catalase + and oxidase - bacilli. 
Then the identification of the bacterial 
genus and species was carried out using 
the Api20E® gallery.
Pseudomonas aeruginosa was identified 
by the presence of blue-green pigments, a 
Gram negative stain, a catalase + test, and 
the presence of an oxidase. The use of the 
Api20NE® gallery allowed the species to 
be confirmed.
Corynebacteria were identified as 
Gram+ irregular bacilli. Then, the 
ApiCoryne® gallery was used.
Statistical Analysis
Statistical analyses were conducted 
using SPSS statistical software, with a 
significance level set at 5%. The medians 
of cell counts obtained were analysed 
over time using the non-parametric 
Friedman test within Groups 1 and 2. 
The means of ISCC obtained on D64 
were compared using the nonparametric 
Wilcoxon-Mann-Whitney test. An 
independence test of two was applied to 
bacteriology results on D64 of subgroups 
A and B of Group 1 to verify the absence 
or presence of a statistical link between 
the two distributions.
Results
In this study, 43 cases of SCM were 
detected by cell count in Group 1 and 
were subjected to bacteriological testing. 
In the first sampling, 23 positive SCC 
samples were sent to the laboratory, in 
the second sampling, 12 positive and 11 
negative samples were sent, and at the 
third sampling, 8 positive and 15 negative 
samples were sent to the laboratory. 
Therefore, the bacteriological analyses in 
this study will only concern the samples 
of Group 1.
Cell counts were conducted on all 
samples in all three samplings (on D0, 
D31, and D64) of both groups. The 
bacteriological results of Group 1 and the 
cell counts of both groups are presented 
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in the first part, while the cell counts of 
both groups is presented in the second 
part.
Bacteriological results of Group 1
Of the 69 samples studied, 26 (37.68%) 
were bacteriologically negative and 
43 (62.31%) quarters were infected. 38 
samples (55.07%) allowed for the isolation 
of a single bacterial species, while 31 
cases (44.92%) gave an association of 
two or three species. The real prevalence 
of udder infections at the end of the 
experiment, i.e., on D64, was 34.78% (8 
positive cases of 23).
Bacteriology on D0
As mentioned above, of the 68 cows 
sampled on D0, 23 samples had a cell 
count greater than or equal to 200,000 cells/
ml and were bacteriologically examined. 
These 23 cows constitute Group 1. Of 
these 23 samples, 6 were mono-bacterial 
and 17 were bi-bacterial, i.e., 26.08% and 
73.91%, respectively. Starting on D0, this 
group was divided into 2 subgroups: A 
(test) and B (control) which were again 
subjected to bacteriological examinations 
on D31 and D64.
Subgroup A
The figure below provides the results 
of the bacteriology of the sample on D0, 
i.e., the different bacterial species isolated 
and their frequencies.
The CNS group was the most 
frequently isolated type (34.62%), 
followed by Escherichia coli (23.08%), 
Staphylococcus aureus, Stenotrophomonas 
maltophilia and Panteoa spp. with 7.69%. 
Finally, we note that no Streptococcus 
species were isolated at this stage.
According to the data, the 
epidemiological model in animal 
husbandry is the mixed model, associating 
environmental and contagious mastitis 
by the presence of different pathogens; 
CNS and Enterobacteriaceae represented 
57.7% of the isolations. Finally, 11 
samples contained two bacterial species 
in association (three samples contained 
CNS and E. coli, two samples contained 
CNS and Panteoa spp., two samples 
contained S. aureus and E. coli, two 
samples contained CNS and S. maltophilia, 
and one sample contained each of CNS 
and Serratia odorifera, and CNS and 
Acinetobacter baumanii,).
Subgroup B
The figure below provides the results 
of the bacteriology of the sample on D0, 
i.e., the bacterial species isolated and their 
frequencies.
S. aureus was the most frequently 
isolated bacterium with 28.57%, followed 
by CNS and Stenotrophomonas maltophilia 
which were isolated at 21.43%. No 
Streptococcus species were isolated at 
Figure 1. Distribution of the bacterial species 
isolated alone or in association, during subclinical 
mastitis on D0, in subgroup A
Figure 2. Distribution of the bacterial species 
isolated alone or in association, during subclinical 
mastitis on D0, in subgroup B
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this stage. Finally, six samples contained 
two bacterial species in association (two 
samples contained CNS and S. maltophilia, 
and one sample each contained S. aureus 
and E. coli, CNS and Serratia odorifera, S. 
aureus and S. maltophilia, S. aureus and 
Citrobacter freundii).
Bacteriology on D31
Bacteriology was performed on the 
23 samples initially included in Group 
1, and only 12 were positive on D31. 
In subgroup A, 7 of the initial 15 cows 
were still positive, giving a decrease in 
the prevalence of bacterial infection of 
53.34%. In subgroup B, 5 of the initial 
8 cows were still positive, resulting in 
a 37.5% decrease in the prevalence of 
infection.
Subgroup A
The figure below shows the isolated 
bacteria and their frequencies on D31.
At this stage, S. aureus was the most 
isolated species with 40%, followed by 
Enterobacter aerogenes with 20%. Bacterial 
associations encountered were: S. aureus 
and Klebsiella pneumoniae spp. pneumoniae, 
S. aureus and Serratia odorifera, S. aureus 
and Pantoea spp 2 and Serratia marcescens, 
S. aureus and S. maltophilia, S. aureus 
and Citrobacter freundii and Enterobacter 
aerogenes.
Subgroup B
Figure 4 shows the isolated bacteria 
and their frequencies on D31.
On D31, S. maltophilia was the most 
frequently isolated species with a 
percentage of 44.44%, followed by S. 
aureus with 33.33%, Serratia odorifera 
and Citrobacter freundii were isolated 
at a frequency of 11.11%. The bacterial 
associations observed in subgroup B on 
D31 were: S. aureus and Serratia odorifera, 
S. aureus and S. maltophilia, S. maltophilia 
and Citrobacter freundii.
Bacteriology on D64
Bacteriology was performed on the 
23 samples initially included in Group 1, 
and only 8 were positive on D64: 5 from 
subgroup A and 3 from subgroup B.
Subgroup A
Figure 5 shows the isolated bacteria 
and their frequencies on D64.
Figure 3. Distribution of the different bacteria 
isolated alone or in association of subclinical 
mastitis on D31, within subgroup A
Figure 4. Distribution of the different bacteria 
isolated alone or in association from subclinical 
mastitis on D31 in subgroup B
Figure 5. Distribution of the different bacterial 
species isolated alone or in association, from 
subclinical mastitis on D64, within subgroup A
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S. maltophilia was the most frequently 
isolated species with 42.86% frequency 
of isolation, followed by Acinetobacter 
baumanii, Citrobacter braaki, Citrobacter 
freundii and Klebsiella pneumoniae spp. 
pneumoniae with 14.29%, respectively. 
The bacteria isolated in association were: 
S. maltophilia and Serratia odorifera, C. 
braakii and S. maltophilia and A. baumanii, 
S. maltophilia and A. baumani,i and S. 
maltophilia and C. freundii.
Subgroup B
Figure 5 shows the isolated bacteria 
and their frequencies on D64.
S. maltophilia was most frequently 
isolated with 60%, followed by Serratia 
odorifera and A. baumanii with 20%. The 
bacterial species isolated in association 
were: S. maltophilia and S. odorifera and S. 
maltophilia and A. baumanii.
Estimation of the bacteriological 
healing of udders
The 23 cases of subclinical mastitis 
which were subjected to three series of 
bacteriological testing and cell counts 
were used to make this estimate. To 
classify the cases as cured/uncured, we 
considered three cases:
 ₋ If the bacteriology on D64 was 
sterile, regardless of the result 
of the first bacteriology, the 
udder was considered to be 
bacteriologically cured.
 ₋ If the result of the bacteriology 
was the same on D31 and D64 
as on D0, the quarter was not 
cured, and the infection was 
persistent.
 ₋ If the bacterial species isolated 
on D31 and/or D64 was different 
from the species isolated on D0, 
the quarter was considered to be 
unhealed, with the occurrence of a 
new infection.
The figure below shows the 
frequencies of the bacterial species 
isolated in the first bacteriology for the 23 
cases tested.
Estimated recovery for all bacteria 
combined
Subgroup A
Of the initial 15 cases of mastitis on 
D0, on D64 we observed: 10 recovery 
cases (66.66%), 2 persistent infections 
(13.33%), and 3 new infections (20%).
Subgroup B
Of the initial 8 cases of mastitis on D0, 
on D64 we observed: 5 recovery cases 
(62.5%), 2 persistent infections (25%), and 
1 new infection (12.5%).
Figure 6. Distribution of the different bacterial 
species isolated alone or in association, from 
subclinical mastitis on D64, within subgroup B
Figure 7. Result of the first bacteriology of the 23 
tested cases
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Estimated recovery for the most 
commonly isolated bacteria
Subgroup A
CNS: Nine cases were analysed, and 
the bacteriological cure rate was 100%.
E. coli: The five cases of initial E. 
coli infection were analysed, and the 
bacteriological cure rate was 100%.
S. aureus: Two cases were analysed, 
and the bacteriological cure rate was 
100%.
S. maltophilia: Two cases of initial 
infection with this species were analysed 
and revealed a 100% cure rate. However, 
three new infections were found on D64.
Subgroup B
CNS: Three cases were analysed and 
the bacteriological cure rate was 100%.
E. coli: Only case of initial E. 
coli infection was analysed, and the 
bacteriological cure rate was 100%.
S. aureus: Four cases were analysed, 
and the bacteriological cure rate was 
100%.
S. maltophilia: Three cases of initial 
infection with this bacteria were analysed 
and revealed a 100% persistence rate of 
infection, thus a 0% cure rate.
Milk somatic cell count results
The Individual Somatic Cell 
Concentrations (ISCC) measured in three 
successive samples of milk (on D0, D31, 
and D64) from both Groups 1 and 2 are 
shown in Table 10.
Group 1
ISCC results on D0
Initially on D0, the two subgroups in 
Group 1 both had an ISCC greater than or 
equal to 200.000 cls/mL.
The quartile diagram of the 
distribution of ISCC (Table 11) shows 
Figure 8. Distribution of ISCC within Group 1 on D0
Table 4. Results of ISCC of the three samples for both Groups 1 and 2
D0 D31 D64 Total
≥ 200,000 cls/mL 23 12 8 43
(%) ISCC ≥ 200,000 cls/mL 53.48% 27.90% 18.60% 100%
< 200,000 cls/mL 45 56 60 161
(%) ISCC <200,000 cls/mL 27.95% 34.78% 37.26% 100%
Table 5. ISCC Quartiles on D0 in Group 1 (cls/mL)
Variable ISCC subgroup A ISCC subgroup B
Q1 (1st quartile) 209.000 209.750
Q2 (median) 236.000 276.000
Q3 (Q3 (3rd quartile) 270.000 362.750
Q3-Q1 61.000 153.000
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that 75% of samples (Q3) had ISCC < 
270.000 cls/mL and ISCC < 362.750 cls/
mL in subgroups A and B, respectively; 
thus 25% of samples (Q1) had ISCC < 
209.000 cls/ml and CCSI < 209.750 cls/ml 
in subgroups A and B, respectively.
The median (Q2) of the distribution of 
ISCC in subgroup A was 236.000 cls/mL, 
so 50% of the samples had an ISCC below 
this median value; and the median (Q2) 
of the distribution of ISCC in subgroup B 
was 276.000 cls/mL, so 50% of the samples 
had an ISCC below this median value. 
The observed values of the interquartile 
range (Q3-Q1) of subgroups A and B are 
61.000 and 153.000 cls/mL, respectively.
ISCC Results on D31
On D31, the proportions were no 
longer the same as on D0; within the two 
subgroups A and B, with 8 and 4 ISCC 
cases, respectively, below the threshold 
of 200.000 cls/mL (below the mastitis 
threshold).
The quartile distribution of ISCC 
(Table 6) shows that 75% of the samples 
(Q3) had ISCC < 180.000 cls/mL and ISCC 
< 383.00 cls/mL in subgroups A and B, 
respectively; thus 25% of the samples 
(Q1) have ISCC < 18.000 cls/mL and ISCC 
< 49.250 cls/mL in subgroups A and B, 
respectively.
The median (Q2) of the distribution of 
ISCC in subgroup A was 37.000 cls/mL, so 
50% of the samples have an ISCC below 
this median value; and the median (Q2) 
of the distribution of ISCC in subgroup B 
is 212.000 cls/mL, so 50% of the samples 
have an ISCC below this median value. 
The observed values of the interquartile 
range (Q3-Q1) of subgroups A and B are 
162.000 and 333.750 cls/mL, respectively.
On D64, drops below the threshold 
were mainly seen in subgroup A with 3 
CCSI (Table 7).
The quartile distribution of the ISCC 
shows that 75% of the samples (Q3) 
had ISCC < 128.000 cls/mL and ISCC < 
297.000 cls/mL in subgroups A and B, 
respectively; thus 25% of the samples 
(Q1) had ISCC < 30.000 cls/mL and ISCC 
< 44.750 cls/mL in subgroups A and B, 
respectively.
The median (Q2) of the distribution of 
CCSI in subgroup A was 47.000 Cls/mL, 
so 50% of the samples had a CCSI below 
Table 6. ISCC Quartiles on D31 in Group 1 (cls/mL)





ISCC results on D64
Table 7. ISCC Quartiles on D64 in Group 1 (cls/mL)
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this median value; and the median (Q2) 
of the distribution of CCSI in subgroup B 
was 126.500 cls/mL, so 50% of the samples 
had a CCSI below this median value. The 
observed values of the interquartile range 
(Q3-Q1) of subgroups A and B were 
98.000 and 252.250 cls/mL, respectively.
Group 2
ISCC results on D0
Initially on D0, both Group 2 
subgroups showed an ISCC result of less 
than 200.000 cls/ml.
The quartile distribution of ISCC 
showed that 75% of the samples (Q3) had 
an ISCC < 39.250 cls/mL and an ISCC < 
44.000 cls/mL in subgroups C and D, 
respectively; thus 25% of the samples 
(Q1) had an ISCC < 9.750 cls/mL and 
ISCC < 22.000 cls/mL in subgroups C and 
D, respectively.
The median (Q2) of the distribution of 
ISCC in subgroup C was 21.500 cls/mL, so 
50% of the samples have an ISCC below 
this median value, and the median (Q2) 
of the distribution of ISCC in subgroup D 
was 26.000 cls/mL, so 50% of the samples 
had an ISCC below this median value.
The observed values of the 
interquartile range (Q3-Q1) of subgroups 
C and D were 29.500 and 22.000 cls/mL, 
respectively.
CCSI results on D31
On D31, the proportions were virtually 
unchanged from D0. In subgroup C, all 
ISCC remained below the threshold of 
200.000 cls/ml, while in subgroup D, only 
one ISCC exceeded 200.000 cls/ml.
The quartile distribution of ISCC 
showed that 75% of samples (Q3) had an 
ISCC < 57.000 cls/ml and ISCC < 49.000 
cls/ml in subgroups C and D, respectively; 
thus 25% of the samples (Q1) had an ISCC 
< 15.500 cls/ml and ISCC < 16.000 cls/ml 
in subgroups C and D, respectively.
The median (Q2) of the distribution of 
ISCC in subgroup C was 23.500 cls/ml, so 
50% of the samples had an ISCC below 
this median value; and the median (Q2) 
of the distribution of ISCC in subgroup D 
was 24.000 cls/ml, so 50% of the samples 
had an ISCC below this median value.
The observed values of the 
interquartile range (Q3-Q1) of subgroups 
C and D were 41.500 and 33.000 cls/ml, 
respectively.
ISCC results on D64
On D64, only two ISCC of subgroup C 
dropped below the threshold.
The quartile distribution of ISCC 
showed that 75% of the samples (Q3) 
had an ISCC < 96.250 cls/mL and ISCC 
< 100.000 cls/mL in subgroups C and D, 
respectively; thus 25% of the samples 
(Q1) had an ISCC < 9.750 cls/mL and 
ISCC < 14.000 cls/mL in subgroups C and 
D, respectively.
The median (Q2) of the distribution of 
ISCC in subgroup C was 38.500 cls/mL, 
so 50% of the samples had an ISCC below 
this median value; and the median (Q2) 
of the distribution of ISCC in subgroup D 
was 35.000 cls/mL, so 50% of the samples 
had an ISCC below this median value.
The observed values of the 
interquartile range (Q3-Q1) of subgroups 
Table 8. ISCC Quartiles on D0 in Group 2 (cls/ml)
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C and D were 86,500 and 86.000 cls/mL, 
respectively.
Monitoring of cell counts over time
The purpose of tracking cell counts 
over time was to evaluate the positive 
or negative evolution of the ISCC within 
each group to evaluate the beneficial or 
negative contribution of SYMBIOVEBA 
on the recovery of cows initially with 
SCM (Group 1), and on the prevention of 
SCM in healthy cows (Group 2).
Group 1
In Group 1, this analysis concerned 
subgroup A, which included fifteen 
cows with SCM that each received a dose 
of the symbiotic after each sampling 
session.
According to the table below, the 
average ISCC on D0 was 235,866.66 cls/
mL and this decreased to 67,933.33 cls/
mL on D64.
The data revealed that the distribution 
structure of ISCC changed significantly 
(P<0.02) over time, improving or 
decreasing, which may suggest a 
beneficial effect of the symbiotic on ISCC, 
and by extrapolation on the recovery of 
SCM cases (in surpassing the mastitis 
threshold)
Group 2
In Group 2, the analysis concerned 
subgroup C which included thirty cows 
initially free of SCM and that received a 
dose of the symbiotic after each sampling 
session.
The results showed that the average of 
ISCC on D0 was 27,533.33 cls/mL, which in-
creased to 84,366.33 cls/mL on D64, but re-
mained below the mastitis threshold. There 
was a significant difference (P<0.05) in the 
distribution structure of ISCC over time, 
though this change was not positive and 
we cannot conclude that the symbiotic had 
a preventive effect on subclinical mastitis.
Status of ISCC on D64: evaluation of 
the symbiotic effect
Group 1
In Group 1, we performed an 
analysis of recovery rates on D64, as the 
proportions of udders considered healed 
compared to unhealed on D64, as shown 
in the table below.
Table 11. Status of ISCC from Group 1 on D64
< S ≥ S
subgroup A 15 0
subgroup B 5 3
Table 9. ISCC descriptive statistics for subgroup A over time
Variable Observations Minimum Maximum Mean Standard deviation
D0 15 135,000.00 310,000.00 235,866.67 46,570.79
D31 15 5000.00 375,000.00 94,866.67 110,740.93
D64 15 2000.00 189,000.00 67,933.33 62,349.78
Table 10. ISCC descriptive statistics for subgroup C over time
Variable Observations Minimum Maximum Mean SD
D0 30 3,000.00 116,000.00 27,533.33 23,998.18
D31 30 5,000.00 143,000.00 40,533.33 36,101.14
D64 30 4,000.00 747,000.00 84,366.67 148,753.55
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Statistical analysis of the data showed 
a significant difference (P<0.05) between 
the two distributions of ISCC values 
on D64, so it can be concluded that 
SYMBIOVEBA had a curative effect on 
lactating cows with SCM.
Group 2
In Group 2, we analysed the 
preventive effect of the symbiotic with 
regard to SCM. The proportions of 
udders considered infected or not on D64 
are shown in the table below.
Table 12. Status of ISCC from Group 2 to D64.
< S ≥ S
subgroup C 28 2
subgroup D 15 0
Statistical analysis of the data showed 
P>0.05 and therefore the results were 
not significantly different. In conclusion, 
this experiment does not offer sufficient 
argument to conclude that SYMBIOVEBA 
has a preventive effect on subclinical 
mastitis.
Analysis of bacteriological recovery 
rates on D64
This analysis concerned the 
bacteriological results of Group 1 on D64. 
The average recovery rate per cow was 
65.21%; specifically, 66.66% in subgroup 
A and 62.5% in subgroup B. We compared 
the results between the subgroups (Table 
24) with the chi-squared test (P=0.84).
Table 13. Distribution of recovery at animal level
Cured Not cured
subgroup A 10 5
subgroup B 5 3
There was no significant difference 
(P>0.05) between the subgroups in the 
bacteriological recovery rates per cow. 
Therefore, from a bacteriological point of 
view, we cannot assert the curative effect 
of SYMBIOVEBA on cows with SCM.
Discussion
In Algeria, several studies have 
been conducted on the prevalence of 
subclinical mastitis and the main bacteria 
responsible for subclinical mastitis in 
cattle farming (Bouaziz, 2005; Boufaida 
et al., 2012; Saidi et al., 2013; Saidi et 
al., 2021a,b). In other countries, feed 
supplementation with additives to 
cure lactating cows or prevent possible 
infection has involved several probiotics 
(Bouchard, 2013). However, to the extent 
of our knowledge, studies on symbiotic 
supplementation and their effect on local 
immune response during subclinical or 
non-subclinical infection have not yet 
been explored.
In this study, the bacteriological 
recovery rate for Group 1 on D64 was 
similar to the report by Rajala-Schultze 
(1983) (68%). Allaire et al. (1991), in a 
study of the efficacy of Cepravin® using 
bacteriology as a diagnostic tool, found 
a high recovery rate of 88%. Similarly, 
Allexandre (2005) found bacteriological 
cure rates of 86% for Cepravin® and 75% 
for Vonapen®.
According to the data, the cure rate 
for staphylococcal infections was higher 
than those reported by different authors 
experimenting with antibiotics: 78% for 
Laval et al. (1990), 76.9% for Charpiat 
(2003). Similar rates were obtained in 
other studies: 85% (Cummins and Mc-
Casey, 1987), 88% (Allaire, 1991) and 93% 
(Stephan et al., 1984). The divergence of 
the results can be explained by the fact 
that Staphylococcus aureus can have intra-
cellular localization and thus become en-
cysted in the parenchyma, meaning that 
the antibiotic-bacterial contact cannot 
always occur properly (Bousquet-Mélou, 
2003). However, this did not prevent bet-
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ter results in our study due to the compo-
sition of SYMBIOVEBA. Indeed, the Lac-
tobacilli were tested in vitro and showed 
an aptitude to produce components such 
as organic acids, hydrogen peroxide, and 
bacteriocins with antimicrobial activity 
(Nader-Macias et al., 2008; Charlier et al., 
2009). Therefore, an intramammary infu-
sion of bacteriocin produced by Lactococ-
cus lactis has shown to be as effective as a 
conventional antibiotic injection (Crispie 
et al., 2008; Klostermann et al., 2008).
CNS cure rates were 100% in our study, 
higher than that reported by Djuricic 
et al. (2014) (61.29%). Enterobacteriaceae 
showed a cure rate of 91.66%, which 
is similar to the report of Djuricic et al. 
(2014) (91.17%) following intramammary 
antibiotic injection during lactation.
Curative activity is defined by a CCSI 
below the cure threshold (S). Recovery 
is complete if the cleansed udder retains 
a CCSI < S on D64. The cure rate for all 
bacterial species combined was 86.95% in 
Group 1; it was the total in subgroup A of 
cows receiving SYMBIOVEBA and 62.5% 
in subgroup B of cows not receiving the 
symbiotic. The difference between the 
two cure rates was significant, conclusive 
of the true curative effect of the symbiotic 
used.
In this study, SYMBIOVEBA had 
a curative activity quite similar to that 
of other products reported by various 
authors: 89% of quarters treated with 
cefalexin (Horlacef) for Leroux (1991), 
93% for Allaire (1991) with cephalonium 
(Cepravin HL), 95% for Lescut (1999) 
with cephalonium (Cepravin HL), and 
87% Charpiat (2003) with rifaximin 
(Fatrox). On the other hand, this rate is 
higher than those obtained by Saurel 
(1993) (84% with cefazolin), Leroux 
(1991) (79% with cloxacillin (Orbenin HL) 
and Charpiat (2003) (77% with cloxacillin 
Orbenin). Meissonnier and Laumonier 
(1991) used individual cell counts to 
evaluate the efficacy of Vonapen® and 
observed a significant drop in cell counts 
for the majority of treated cows from 71% 
to 83%.
The cure rate based on CCSI was 
higher than observed bacteriologically, 
and this could be explained by the cure 
threshold set at 200,000 cls/mL, as there 
may also be bacterial infection below this 
rate, as reported by Djabri et al. (2002), 
who stated that quarters with SCCs 
between 110,000 and 150,000 cls/mL 
were considered to have minor bacterial 
infections. This was the case in our 
study, where samples at CCSI < S present 
minor bacterial infections (S. maltophilia, 
Klebsiella pneumoniae, Citrobacter brakii, 
Citrobacter freundii and Cinetobacter 
baumanii isolated at: 50%, 12.5%, 12.5%, 
12.5% frequency, respectively).
Preventive activity was assessed by 
CCSI < S in Group 2 cows. No preventive 
activity of SYMBIOVEBA was observed 
in our study due to the non-significant 
difference between the means of CCSI of 
the experimental and control subgroups 
on D64. This may have been due to the 
small sample size or to the hygienic 
conditions of milking or breeding.
Conclusions
To conclude, the combination of CCSI 
and bacteriological analysis of all cows 
provided precise and timely information 
on the aetiology and frequency of 
subclinical mastitis at the farm. On the 
other hand, the combination of two 
of three successive samples offers the 
possibility of monitoring the present 
infection, detecting new infections, 
and estimating the rate of cure with or 
without treatment.
The administration of SYMBIOVE-
BA® to cows suffering from subclinical 
mastitis during lactation showed a con-
siderable curative effect. The preventive 
effect of SYMBIOVEBA® on healthy cows 
against subclinical mastitis was not con-
cluded in our study, and future studies 
including a larger number of cows and 
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over a longer period of time will be nec-
essary to explore its possible preventive 
activity.
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Mastitis krava predstavlja važan 
ekonomski i sanitarni trošak u proizvodnji 
mlijeka. Prevencija i liječenje ove bolesti u 
osnovi se temelje na uporabi antibiotika koji 
negativno utječu na kakvoću mlijeka i čija je 
učinkovitost ograničena. Cilj je ove studije bio 
procijeniti učinkovitost alternativnog liječenja 
na temelju simbioze kontrole i prevencije 
subkliničkog mastitisa (SCM) te poboljšanja 
kakvoće mlijeka koje se proizvodi na farmi 
mlijeka koja se nalazi u sjevernom središtu 
Alžira. Prikupljeno je mlijeko 68 krava te 
analizirano prema broju somatskih stanica, 
a učinjena je i bakteriološka analiza. Izuzeta 
su tri različita uzorka u intervalu od mjesec 
dana. Prvi je uzorak izuzet prije davanja 
dodatka prehrani (SYMBIOVEBA®) mliječnim 
kravama u laktaciji. Životinje su klasificirane 
u 2 skupine kako bi se proučila dva učinka 
(ljekoviti i preventivni) simbioze. Svaka 
skupina podijeljena je u dvije skupine, jedna 
je primala simbiozu, a druga je bila kontrolna 
skupina. Pojavnost subkliničkog mastitisa 
na ovoj farmi bila je 33,82 %. Identifikacija 
mikroorganizama provedena je klasičnom 
metodom i odnosila se samo na skupinu 
krava s mastitisom na početku; to je dopustilo 
izolaciju 13 različitih mikroorganizama iz tri 
uzastopno uzorkovana uzorka. Otkrivena je 
dominacija stafilokoka s učestalošću od 45 % 
i enterobakterija (40 %). Ovi su postotci bili 
značajno niži u obje skupine, osim što je to bilo 
značajnije u liječenih krava: 100 % izlječenja za 
stafilokoke i enterobakterije. Broj somatskih 
stanica u mlijeku pojedine krave (ISCC) ispitan 
je u sva tri uzorka i u obje skupine je otkrio, za 
prag uporabe terapije (S) od 200,000 stanica/
mL, 100 % postotak izlječenja za skupinu 
krava koje su primale SYMBIOVEBA® dodatak 
prehrani u usporedbi sa 62,5 % za kontrolnu 
skupinu krava (P<0,05). 
Ključne riječi: mliječna krava, subklinički 
mastitis, bakteriologija, BSS u mlijeku pojedine 
krave, simbioza
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